Read-Gene S.A. (WSE:RDG)
Poland · Delayed Price · Currency is PLN 4.860
+0.180 (3.85%)
At close: Jul 24, 2026
Read-Gene Market Cap
Read-Gene has a market cap or net worth of 57.3 million as of July 24, 2026. Its market cap has decreased by -6.90% in one year.
Market Cap
57.30M
Enterprise Value
61.28M
Revenue
16.54M
Ranking
n/a
PE Ratio
29.39
Stock Price
4.86
ChartMarket Cap Chart
Since February 12, 2009, Read-Gene's market cap has increased from 31.83M to 57.30M, an increase of 80.00%. That is a compound annual growth rate of 3.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 57.30M | -10.99% |
| Dec 30, 2025 | 64.37M | 10.08% |
| Dec 30, 2024 | 58.48M | -14.48% |
| Dec 29, 2023 | 68.38M | 124.81% |
| Dec 30, 2022 | 30.42M | -8.19% |
| Dec 29, 2021 | 33.13M | 8.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.53B |
| NEUCA | 3.36B |
| Synektik Spólka Akcyjna | 3.07B |
| Voxel | 1.26B |
| Urteste | 71.12M |
| Genomtec | 65.76M |
| Milton Essex Spólka Akcyjna | 49.35M |
| BioMaxima | 42.52M |